Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: business

Innovation is key for developing the future of agriculture and sometimes it comes from unlikely places.

The NASA Artemis Mission is working to develop space exploration, but here on Earth, they are partnering with the University of California Berkeley to use Land Satellite Seven to benefit agriculture.

According to NASA Administrator Jim Bridenstine, “We can use that data from space and combine it with weather stations from Earth, and we can get very precise evapotranspiration measurements, down to a quarter of an acre. What that means is we can provide farmers with very specific irrigation plans.”

The technology is still in the testing phase but could one day make farming a little easier. “Imagine being a farmer and going out into your field with your iPhone, looking at it and having an app on there that tells you exactly what your irrigation needs to be for this quarter of an acre for this type of soil and this type of crop,” Bridenstine states.

NASA looks to partner with private businesses to bring new technologies to the market. “The challenge is land sat only has a revisit of two weeks,” he notes. “Weather changes a lot in two weeks; so, I think there is a future where a commercial company could create lots of satellites that could provide this data to farmers.”

Another project on the International Space Station, called Eco-Stress, measures heat stress in plants using infrared technology. Both projects hope to answer a key question: “Can we use our earth science capabilities to feed more of the world and save water in the central valley of California, and the answer is— yes we can.”

The NASA Artemis Mission looks to help benefit agriculture by using data from space and combining it with weather stations to improve irrigation practices.

Read more | >

The coronavirus has wreaked havoc on our world’s economy, and many scientists and nations are scrambling to get a vaccine out. In today’s video, I will talk about what will happen when that vaccine actually appears:

Discord Link: https://discord.gg/brYJDEr
Patreon link: https://www.patreon.com/TheFuturistTom
Please follow our instagram at: https://www.instagram.com/the_futurist_tom
For business inquires, please contact [email protected]

Read more | >

Shalev Hulio wants to explain himself.

Normally, silence and secrecy are inherent in the spy business. For nine full years, Hulio never talked publicly about his billion-dollar hacking company—even when his hacking tools were linked to scandal or he was accused of being complicit in human rights abuses around the world. Lately, though, he’s speaking up.

“People don’t understand how intelligence works,” Hulio tells me over a video call from Tel Aviv. “It’s not easy. It’s not pleasant. Intelligence is a shitty business full of ethical dilemmas.”

Read more | >

The MIT-Harvard Medical School Healthcare Innovation Bootcamp brings the rigorous, collaborative, action-learning experience of our in-person Healthcare Innovation Bootcamps online. Over 10 weeks, you’ll have the opportunity to work with a global team of innovators selected by MIT Bootcamps to build the foundations of a new healthcare venture. You will learn principles… See More.

The MIT — Harvard Medical School Healthcare Innovation Bootcamp will be different than most online courses you can take. A combination of live teaching sessions and workshops (which are recorded for your flexibility), office hours, building the foundations of a venture with your global team, and receiving regular team-based coaching, the Bootcamp is a hands-on, immersive, and rigorous learning experience. In 10 weeks, you’ll learn to identify an innovation opportunity, develop a superior solution, and select a business model for the venture you build with your global team. Expect to spend 10–15 hours per week on live sessions, individual, and team work.

Read more | >

In a bitter paradox, antibiotics fuelled the growth of the twentieth century’s most profitable pharmaceutical companies, and are one of society’s most desperately needed classes of drug. Yet the market for them is broken. For almost two decades, the large corporations that once dominated antibiotic discovery have been fleeing the business, saying that the prices they can charge for these life-saving medicines are too low to support the cost of developing them. Most of the companies now working on antibiotics are small biotechnology firms, many of them running on credit, and many are failing.

Paratek Pharmaceuticals successfully brought a new antibiotic to the market. So why is the company’s long-term survival in question?

Read more | >

Humans will soon have new bodies that forever blur the line between the natural and synthetic worlds, says bionics designer Hugh Herr. In an unforgettable talk, he details “NeuroEmbodied Design,” a methodology for creating cyborg function that he’s developing at the MIT Media Lab, and shows us a future where we’ve augmented our bodies in a way that will redefine human potential — and, maybe, turn us into superheroes. “During the twilight years of this century, I believe humans will be unrecognizable in morphology and dynamics from what we are today,” Herr says. “Humanity will take flight and soar.”

Check out more TED Talks: http://www.ted.com

The TED Talks channel features the best talks and performances from the TED Conference, where the world’s leading thinkers and doers give the talk of their lives in 18 minutes (or less). Look for talks on Technology, Entertainment and Design — plus science, business, global issues, the arts and more.

Follow TED on Twitter: http://www.twitter.com/TEDTalks
Like TED on Facebook: https://www.facebook.com/TED

Read more | >

OpenAI’s new language generator #GPT-3 is shockingly good—and completely mindless: https://bit.ly/3kphfsX

By Will Douglas Heavenarchive page from MIT Technolgy Review

#AI #MachineLearning #NeuralNetworks #DeepLearning

“Playing with GPT-3 feels like seeing the future,” Arram Sabeti, a San Francisco–based developer and artist, tweeted last week. That pretty much sums up the response on social media in the last few days to OpenAI’s latest language-generating AI.

OpenAI first described GPT-3 in a research paper published in May. But last week it began drip-feeding the software to selected people who requested access to a private beta. For now, OpenAI wants outside developers to help it explore what GPT-3 can do, but it plans to turn the tool into a commercial product later this year, offering businesses a paid-for subscription to the AI via the cloud.

Read more | >